These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 25861727)

  • 41. Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment.
    Costa PM; Cardoso AL; Mendonça LS; Serani A; Custódia C; Conceição M; Simões S; Moreira JN; Pereira de Almeida L; Pedroso de Lima MC
    Mol Ther Nucleic Acids; 2013 Jun; 2(6):e100. PubMed ID: 23778499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
    Teplyuk NM; Uhlmann EJ; Wong AH; Karmali P; Basu M; Gabriely G; Jain A; Wang Y; Chiocca EA; Stephens R; Marcusson E; Yi M; Krichevsky AM
    Oncotarget; 2015 Feb; 6(6):3770-83. PubMed ID: 25738367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-based therapy for glioblastoma: Opportunities and challenges.
    Lei Q; Yang Y; Zhou W; Liu W; Li Y; Qi N; Li Q; Wen Z; Ding L; Huang X; Li Y; Wu J
    Eur J Pharmacol; 2023 Jan; 938():175388. PubMed ID: 36403686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma.
    Liu H; Liu Z; Jiang B; Huo L; Liu J; Lu J
    Cell Biochem Biophys; 2015 Jun; 72(2):551-7. PubMed ID: 25564360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
    She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
    Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma.
    D'Amico R; Lei L; Kennedy BC; Sisti J; Ebiana V; Crisman C; Christensen JG; Gil O; Rosenfeld SS; Canoll P; Bruce JN
    Neurol Res; 2012 Apr; 34(3):252-61. PubMed ID: 22449730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles.
    Liu XQ; Song WJ; Sun TM; Zhang PZ; Wang J
    Mol Pharm; 2011 Feb; 8(1):250-9. PubMed ID: 21138272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence.
    Sandhanam K; Tamilanban T; Manasa K; Bhattacharjee B
    Neuroscience; 2024 Aug; 553():1-18. PubMed ID: 38944146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.
    Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH
    Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.
    Seo YE; Suh HW; Bahal R; Josowitz A; Zhang J; Song E; Cui J; Noorbakhsh S; Jackson C; Bu T; Piotrowski-Daspit A; Bindra R; Saltzman WM
    Biomaterials; 2019 May; 201():87-98. PubMed ID: 30802686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme.
    Pottoo FH; Javed MN; Rahman JU; Abu-Izneid T; Khan FA
    Semin Cancer Biol; 2021 Feb; 69():391-398. PubMed ID: 32302695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
    Chan JA; Krichevsky AM; Kosik KS
    Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
    Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
    Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
    Kouri FM; Ritner C; Stegh AH
    Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.
    Stojcheva N; Schechtmann G; Sass S; Roth P; Florea AM; Stefanski A; Stühler K; Wolter M; Müller NS; Theis FJ; Weller M; Reifenberger G; Happold C
    Oncotarget; 2016 Mar; 7(11):12937-50. PubMed ID: 26887050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.